Ramirez Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Ramirez Asset Management's BMY Position: Q2 2026 in Review
Ramirez Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2,222% in Q2 2026, buying an estimated $276K and bringing the position to 5,016 shares worth $289K. The position accounts for 0.03% of the portfolio, ranked #188.
Ramirez Asset Management first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.14M in Q3 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ramirez Asset Management held 5,016 shares of Bristol-Myers Squibb worth $289K as of Q2 2026.
- Ramirez Asset Management bought 4,800 Bristol-Myers Squibb shares in Q2 2026, an estimated $276K.
- Bristol-Myers Squibb made up 0.03% of Ramirez Asset Management's portfolio in Q2 2026, its #188 holding.
- Ramirez Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- Ramirez Asset Management's Bristol-Myers Squibb position peaked at $1.14M in Q3 2023.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.